Volitionrx (VNRX) Shareholder's Equity (QoQ) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.99% |
| Sep 30, 2025 | -8.61% |
| Jun 30, 2025 | -14.03% |
| Mar 31, 2025 | -16.54% |
| Dec 31, 2024 | -10.01% |
| Sep 30, 2024 | 1.12% |
| Jun 30, 2024 | -37.77% |
| Mar 31, 2024 | -90.77% |
| Dec 31, 2023 | -205.55% |
| Sep 30, 2023 | -155.71% |
| Jun 30, 2023 | 271.68% |
| Mar 31, 2023 | 4.66% |
| Dec 31, 2022 | -210.11% |
| Sep 30, 2022 | -30.38% |
| Jun 30, 2022 | -62.27% |
| Mar 31, 2022 | -39.00% |
| Dec 31, 2021 | -16.33% |
| Sep 30, 2021 | -20.46% |
| Jun 30, 2021 | -14.55% |
| Mar 31, 2021 | 91.26% |
| Dec 31, 2020 | -14.07% |
| Sep 30, 2020 | 1.60% |
| Jun 30, 2020 | 103.18% |
| Mar 31, 2020 | -35.31% |
| Dec 31, 2019 | -20.24% |
| Sep 30, 2019 | 8.66% |
| Jun 30, 2019 | 8.42% |
| Mar 31, 2019 | 24.47% |
| Dec 31, 2018 | -19.64% |
| Sep 30, 2018 | 50.34% |
| Jun 30, 2018 | -28.29% |
| Mar 31, 2018 | 40.73% |
| Jun 30, 2013 | -1.80% |
| Mar 31, 2013 | -17.12% |
| Dec 31, 2012 | -25.62% |
| Sep 30, 2012 | -7.34% |
| Jun 30, 2012 | 24.66% |
| Mar 31, 2012 | -10.89% |